Medicare

Oberheiden P.C. Welcomes Former Federal Prosecutor Jennifer W. Corinis as New Litigation Counsel

Retrieved on: 
Friday, March 15, 2024

, a premier Dallas-based litigation and compliance firm, proudly announces the addition of Jennifer W. Corinis to its team as Litigation Counsel.

Key Points: 
  • , a premier Dallas-based litigation and compliance firm, proudly announces the addition of Jennifer W. Corinis to its team as Litigation Counsel.
  • With a distinguished 25-year career that spans across various sectors of the legal system, Corinis brings a wealth of experience and expertise, particularly in federal civil and criminal litigation, as well as appeals.
  • Before joining Oberheiden P.C., Jennifer W. Corinis dedicated 14 years of her career to serving as a federal prosecutor, where she honed her skills in the courtroom, successfully trying a dozen federal cases on behalf of the United States and arguing numerous cases before the United States Court of Appeals.
  • Throughout her illustrious career, Corinis has achieved notable successes in defending federal agencies, companies, and individuals in high-stakes litigation.

DATA BREACH ALERT: Edelson Lechtzin LLP is Investigating Claims on Behalf of Customers Whose Personal Data May Have Been Compromised by the Greylock McKinnon Associates, Inc. Data Breach

Retrieved on: 
Tuesday, April 9, 2024

NEWTOWN, Pa., April 09, 2024 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a national class action law firm, is investigating claims regarding data privacy violations by Greylock McKinnon Associates, Inc. Greylock McKinnon learned of suspicious activity on or about May 30, 2023.

Key Points: 
  • NEWTOWN, Pa., April 09, 2024 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a national class action law firm, is investigating claims regarding data privacy violations by Greylock McKinnon Associates, Inc. Greylock McKinnon learned of suspicious activity on or about May 30, 2023.
  • On or about May 30, 2023, Greylock McKinnon detected unusual activity on its internal network and took action to address the situation, including consulting with third-party cybersecurity experts about the incident.
  • How can I protect my personal data?
  • Edelson Lechtzin LLP is investigating bringing a class action lawsuit to seek legal remedies on behalf of customers who may have had their sensitive personal and patient data compromised by the Greylock McKinnon data breach.

Aspira Women’s Health Announces Anthem Blue Cross to Provide Coverage for OvaSuite(SM) in California

Retrieved on: 
Tuesday, April 9, 2024

Anthem Blue Cross will provide coverage for its commercial and government lines of business, including Medicare Advantage and Medicaid, which represents a total of approximately six million covered lives in California.

Key Points: 
  • Anthem Blue Cross will provide coverage for its commercial and government lines of business, including Medicare Advantage and Medicaid, which represents a total of approximately six million covered lives in California.
  • “We are very pleased to add Anthem Blue Cross to our list of payers providing coverage for our OvaSuite portfolio, which provides a clear benefit to physicians in their clinical assessment of women with adnexal masses,” said Torsten Hombeck, Chief Financial Officer of Aspira.
  • Our strategic focus on payer adoption continues to gather momentum.”
    Anthem is a leading health company dedicated to improving lives and communities.
  • Through its affiliated companies, Anthem serves more than 118 million people, including more than 45 million within its family of health plans.

New Research From Inovalon and Harvard Analyzes Medicare Advantage Plan Design Impact on Healthcare Utilization and Health Equity

Retrieved on: 
Monday, April 8, 2024

The findings, published in the white paper " The Importance of Plan Design in Medicare Advantage ," represent the fourth installment of Inovalon’s and Harvard Medical School’s research collaboration to understand the underlying factors influencing enrollment, quality outcomes, and utilization in MA vs. FFS Medicare.

Key Points: 
  • The findings, published in the white paper " The Importance of Plan Design in Medicare Advantage ," represent the fourth installment of Inovalon’s and Harvard Medical School’s research collaboration to understand the underlying factors influencing enrollment, quality outcomes, and utilization in MA vs. FFS Medicare.
  • Previous research found that MA delivers superior quality outcomes and utilization reductions compared to FFS Medicare, even after controlling for differences in who enrolls.
  • However, until now, there was limited data on the differences within MA, and how specific MA plan designs and features impact outcomes.
  • "By understanding the populations Medicare Advantage plans attract, policymakers and health plans can come together to incentivize and deliver superior, cost-effective outcomes for every Medicare enrollee."

Samsung Bioepis Releases Second Quarter 2024 US Biosimilar Market Report

Retrieved on: 
Monday, April 8, 2024

The 5th edition explores some IRA implications on biosimilars along with latest price trends, biosimilars market share

Key Points: 
  • The 5th edition explores some IRA implications on biosimilars along with latest price trends, biosimilars market share
    INCHEON, Korea, April 08, 2024 (GLOBE NEWSWIRE) -- Samsung Bioepis Co., Ltd. today released its Second Quarter 2024 Biosimilar Market Report , which includes the latest Average Sales Price (ASP) information of all biosimilars and reference products available in the US market.
  • This fifth-edition of the Samsung Bioepis Quarterly Biosimilar Market Report delves into some implications of the Inflation Reduction Act (IRA) with respect to biosimilars, as well as the biosimilars market share and price trends.
  • “Over the past year, we have strived to provide the US market with the latest biosimilar insights through our report, and we are grateful for the positive reception from our readers,” said Thomas Newcomer, Vice President, Head of Market Access, US, at Samsung Bioepis.
  • As of February 2024, adalimumab biosimilar market share has reached 4%, increasing 2% compared to the previous quarter.

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages agilon health, inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AGL

Retrieved on: 
Sunday, April 7, 2024

WHAT TO DO NEXT: To join the agilon class action, go to https://rosenlegal.com/submit-form/?case_id=23637 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the agilon class action, go to https://rosenlegal.com/submit-form/?case_id=23637 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Kessler Topaz Meltzer & Check, LLP Announces Securities Class Action Lawsuit Filed Against HireRight Holdings Corporation (HRT)

Retrieved on: 
Saturday, April 6, 2024

RADNOR, Pa., April 06, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Middle District of Tennessee against HireRight Holdings Corporation (“HireRight”) ( NYSE: HRT ).

Key Points: 
  • RADNOR, Pa., April 06, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Middle District of Tennessee against HireRight Holdings Corporation (“HireRight”) ( NYSE: HRT ).
  • The action charges HireRight with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.
  • Kessler Topaz Meltzer & Check, LLP encourages HireRight investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The class action complaint against HireRight, Deutsch v. HireRight Holdings Corporation, et al., Case No.

CLASS ACTION ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Has Filed A Securities Fraud Class Action Lawsuit Against agilon health, inc.

Retrieved on: 
Saturday, April 6, 2024

RADNOR, Pa., April 06, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ( NYSE: AGL ) (“agilon” or the “Company”).

Key Points: 
  • RADNOR, Pa., April 06, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ( NYSE: AGL ) (“agilon” or the “Company”).
  • The filing of the Hope Action does not change the May 20, 2024, lead plaintiff deadline.
  • Kessler Topaz Meltzer & Check, LLP encourages agilon investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Agilon, NBH, and Shoals and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, April 6, 2024

In return, agilon takes on the responsibility of managing the total cost and quality of care for those patients.

Key Points: 
  • In return, agilon takes on the responsibility of managing the total cost and quality of care for those patients.
  • This model incentivizes agilon and its contracted physician partners to focus on preventive care and improve health outcomes in order to control costs.
  • If the total cost of caring for patients is less than the fixed payments agilon receives, it realizes a profit.
  • Securities analysts were shocked by the disclosure and linked Shoals’ sharp stock price decline to the warranty charge.

Ascend Broker to Launch at Medicarians 2024

Retrieved on: 
Friday, April 5, 2024

Bloom, an insurance services and technology provider, will launch its new multi-carrier quote-and-enroll technology tool, Ascend Broker, at Medicarians 2024 on Tuesday, April 9 in Las Vegas, Nevada.

Key Points: 
  • Bloom, an insurance services and technology provider, will launch its new multi-carrier quote-and-enroll technology tool, Ascend Broker, at Medicarians 2024 on Tuesday, April 9 in Las Vegas, Nevada.
  • Bloom Founder and Chief Executive Officer, Sherman Rogers, will also speak on the Plenary Stage on April 9 at 8 a.m. Pacific time on the topic of, “3 Keys to Navigating the Medicare Advantage Storm: Understanding CMS Changes, Potential Impacts, and Using Both to Your Advantage.”
    To learn more about Medicarians, visit www.medicarians.com .